Federal funds can't be used to give test strips to drug users, raising overdose fears — 2026-08-08

カートのアイテムが多すぎます

ご購入は五十タイトルがカートに入っている場合のみです。

カートに追加できませんでした。

しばらく経ってから再度お試しください。

ウィッシュリストに追加できませんでした。

しばらく経ってから再度お試しください。

ほしい物リストの削除に失敗しました。

しばらく経ってから再度お試しください。

ポッドキャストのフォローに失敗しました

ポッドキャストのフォロー解除に失敗しました

Federal funds can't be used to give test strips to drug users, raising overdose fears — 2026-08-08

無料で聴く

ポッドキャストの詳細を見る

## Short Segments Teen cannabis use is linked to slower memory and thinking growth, according to new research from the University of California, San Diego. Today, we'll explore how cannabis affects adolescent brain development, and later, we'll dive into the implications of federal funding restrictions on test strips for drug users. Researchers have found that teenagers who begin using cannabis may experience slower growth in cognitive abilities such as memory, attention, language, and processing speed. The study, published in Neuropsychopharmacology, analyzed data from over 11,000 participants in the Adolescent Brain Cognitive Development Study, the largest long-term study of brain development in U.S. youth. While these abilities often develop normally at first, they tend to level off in cannabis users, whereas non-users continue to improve. THC, the psychoactive component of cannabis, appears to be the most likely driver of these changes, particularly affecting memory. This research highlights the critical period of adolescence for brain development and suggests that cannabis use during these years could have lasting impacts on cognitive growth. As cannabis becomes more accessible, understanding its effects on young brains is crucial for parents, educators, and policymakers. ## Feature Story Federal funds can no longer be used to provide test strips to drug users, raising concerns about increased overdose risks. The Trump administration's decision to restrict the use of federal funds for fentanyl test strips marks a significant shift away from harm reduction strategies. Test strips are a critical tool for identifying dangerous additives in street drugs, such as fentanyl, which can significantly increase the risk of overdose. Public health groups and local health departments have relied on these strips to help prevent fatal overdoses, especially in areas with high rates of drug use. In Baltimore, for example, three mass overdose incidents occurred within three months in the Penn North neighborhood. In one incident, more than two dozen people were hospitalized after being found unresponsive. Follow-up testing revealed that the street drugs involved contained dangerous contaminants. The Substance Abuse and Mental Health Services Administration (SAMHSA) issued an open letter in April, ordering an end to the use of its funding for all substance testing strips, including those for fentanyl, xylazine, and medetomidine. This decision has baffled public health organizations, who warn that it could reverse progress made in combating fatal overdoses. Critics argue that the move could have fatal consequences, as it removes a key tool for harm reduction. Without federal funding, local health departments and nonprofits may struggle to provide these test strips to those who need them most. As the opioid crisis continues to evolve, the need for effective harm reduction strategies remains critical. The decision to restrict funding for test strips could hinder efforts to prevent overdoses and save lives. Looking ahead, public health advocates are calling for a reevaluation of this policy, emphasizing the importance of harm reduction in addressing the ongoing drug crisis. The debate over federal funding for test strips highlights the broader challenges in balancing public health priorities with policy decisions. As the situation develops, stakeholders will be watching closely to see how this policy change impacts overdose rates and public health efforts across the country.

まだレビューはありません